A novel autoantibody signatures for enhanced clinical diagnosis of pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease that requires precise diagnosis for effective treatment. However, the diagnostic value of carbohydrate antigen 19 − 9 (CA19-9) is limited. There...
Source: Cancer Cell International - Category: Cancer & Oncology Authors: Tiandong Li, Junfen Xia, Huan Yun, Guiying Sun, Yajing Shen, Peng Wang, Jianxiang Shi, Keyan Wang, Hongwei Yang and Hua Ye Tags: Research Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Carbohydrates | Pancreas | Pancreatic Cancer